Myeloid leukemias are among the most aggressive blood cancers and have low survival rates. Today, leukemia patients undergo ...
In this video, Jennifer A. Woyach, MD, discusses two abstracts from ASH Annual Meeting and Exhibition that evaluated the use of immune therapies to treat chronic lymphocytic leukemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results